1. 229 Discovery of ganglioside GM2 activator as a novel proteomic biomarker associated with response to treatment in first-line melanoma subjects treated with PD-1 immunotherapy. (9th November 2020) Authors: Beeler, Kristina; Vowinckel, Jakob; Soste, Martin; Mallardo, Domenico; Capone, Mariaelena; Gabriele, Madonna; Sorrentino, Antonio; Vanella, Vito; Sklodowski, Kamil; Heinzmann, Daniel; Ascierto, Paolo Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 229 Discovery of ganglioside GM2 activator as a novel proteomic biomarker associated with response to treatment in first-line melanoma subjects treated with PD-1 immunotherapy. (9th November 2020) Authors: Beeler, Kristina; Vowinckel, Jakob; Soste, Martin; Mallardo, Domenico; Capone, Mariaelena; Gabriele, Madonna; Sorrentino, Antonio; Vanella, Vito; Sklodowski, Kamil; Heinzmann, Daniel; Ascierto, Paolo Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. Issue 1 (16th July 2018) Authors: Capone, Mariaelena; Giannarelli, Diana; Mallardo, Domenico; Madonna, Gabriele; Festino, Lucia; Grimaldi, Antonio Maria; Vanella, Vito; Simeone, Ester; Paone, Miriam; Palmieri, Giuseppe; Cavalcanti, Ernesta; Caracò, Corrado; Ascierto, Paolo Antonio Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of a Novel Polymorphism in PPARG Regulatory Region Associated with Type 2 Diabetes and Diabetic Retinopathy in Italy. (1st December 2008) Authors: Costa, Valerio; Casamassimi, Amelia; Esposito, Katherine; Villani, Angela; Capone, Mariaelena; Iannella, Rosa; Schisano, Bruno; Ciotola, Miryam; Di Palo, Carmen; Capone Corrado, Feliciantonia; Santangelo, Franco; Giugliano, Dario; Ciccodicola, Alfredo Other Names: El Shanti Hatem Academic Editor. Journal: Journal of biomedicine and biotechnology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents. Issue 3 (10th March 2022) Authors: Turiello, Roberta; Capone, Mariaelena; Morretta, Elva; Monti, Maria Chiara; Madonna, Gabriele; Azzaro, Rosa; Del Gaudio, Pasquale; Simeone, Ester; Sorrentino, Antonio; Ascierto, Paolo A; Morello, Silvana Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients. (1st February 2017) Authors: Tallerico, Rossana; Cristiani, Costanza M.; Staaf, Elina; Garofalo, Cinzia; Sottile, Rosa; Capone, Mariaelena; Pico de Coaña, Yago; Madonna, Gabriele; Palella, Eleonora; Wolodarski, Maria; Carannante, Valentina; Mallardo, Domenico; Simeone, Ester; Grimaldi, Antonio M.; Johansson, Sofia; Frumento,... Journal: Oncoimmunology Issue: Volume 6:Number 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunoscore: a new possible approach for melanoma classification. (6th November 2014) Authors: Capone, Mariaelena; Madonna, Gabriele; Sebastiao, Noemi; Bird, Jean; Ayala, Fabrizio; Caracò, Corrado; Ciliberto, Gennaro; La Fleur, Bonnie; Mozzillo, Nicola; Botti, Gerardo; Tubbs, Alisa; Ascierto, Paolo Antonio Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016) Authors: Nanda, Vashisht; Peng, Weiyi; Hwu, Patrick; Davies, Michael; Ciliberto, Gennaro; Fattore, Luigi; Malpicci, Debora; Aurisicchio, Luigi; Ascierto, Paolo; Croce, Carlo; Mancini, Rita; Spranger, Stefani; Gajewski, Thomas; Wang, Yangyang; Ferrone, Soldano; Vanpouille-Box, Claire; Wennerberg, Erik; Pil... Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab. (2nd December 2018) Authors: Madonna, Gabriele; Ballesteros-Merino, Carmen; Feng, Zipei; Bifulco, Carlo; Capone, Mariaelena; Giannarelli, Diana; Mallardo, Domenico; Simeone, Ester; Grimaldi, Antonio M.; Caracò, Corrado; Botti, Gerardo; Fox, Bernard A.; Ascierto, Paolo A. Journal: Oncoimmunology Issue: Volume 7:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab. (September 2016) Authors: Wistuba-Hamprecht, Kilian; Martens, Alexander; Haehnel, Karin; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael A.; Wong, Phillip; Romano, Emanuela; Khammari, Amir; Dreno, Brigitte; Capone, Mariaelena; Ascierto, Paolo A.; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth; Larbi, Anis; Schilling, B... Journal: European journal of cancer Issue: Volume 64(2016) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗